Fairgate Group Limited — Financial Health Assessment

Company Overview: Private limited company (group), incorporated 1988. Activities of head offices (SIC 70100). Registered in England & Wales.

1. Financial Health Score: C+

Explanation: The patient is alive and functioning but showing chronic symptoms of financial strain. While the group possesses a substantial investment property portfolio (£73.3M) providing a foundation of value, the business is experiencing gradual net asset erosion, persistent working capital deficits at the consolidated level, and heavy reliance on related-party funding to remain viable. The going concern basis is explicitly dependent on continued support from the ultimate controlling party — a lifeline that, if withdrawn, could prove fatal.

2. Key Vital Signs

Consolidated Balance Sheet Metrics (Year Ended 31 December 2025)

Company-Level Balance Sheet Metrics

Historical Net Asset Trajectory (Company Level)

Net assets have declined approximately 13% over seven years — a slow but persistent bleed.

3. Diagnosis

Symptoms Analysis

🩸 Chronic Working Capital Deficit (Consolidated) The consolidated balance sheet reveals net current liabilities of £30.6M — meaning short-term obligations vastly exceed short-term assets. This is the financial equivalent of a patient whose oxygen intake doesn't meet demand. The business is structurally dependent on group and related company loans classified within current liabilities to fund operations. While the accounts note the ultimate controlling party has stated intent to provide support, this is explicitly described as not creating a contractual obligation. This is a going concern risk factor that warrants close monitoring.

📉 Investment Property Devaluation The investment property portfolio was revalued downward by approximately £8.3M (from £81.6M to £73.3M) in a single year. The investment property revaluation reserve dropped from £16.4M to £9.5M. This suggests either market conditions affecting the property portfolio, specific property issues, or a correction of previously optimistic valuations. This is the primary driver of the consolidated net asset decline from £31.6M to £26.3M.

💸 Marginal Profitability Turning Negative At the company level, the business swung from a £130k profit (2024) to a £93k loss (2025). Over the longer term, net assets have been eroding gradually — the business is not generating sufficient retained earnings to grow equity. The P&L reserve has declined from £4.49M (2018 net assets, predominantly retained earnings) to £264k (2025), suggesting accumulated losses or distributions have significantly depleted reserves.

💉 Heavy Related-Party Funding Dependence The company-level balance sheet shows £51.9M in debtors (largely intercompany) and £37.5M in current liabilities (largely group loans). The business operates as a financial conduit within a group structure, channeling funds between related entities. This is characteristic of a head office operation but creates concentration risk — the company's health is inextricably linked to the health of the wider group.

🫀 Cash Flow Volatility Cash positions have swung dramatically: £12.2M (2019) → £10.1M (2020) → £3.9M (2021) → £0.79M (2024) → £1.98M (2025). The 2024 cash position was dangerously low. While 2025 shows improvement, the volatility indicates the company is managing cash tightly with little buffer.

✅ Positive Signs - Current liabilities reduced from £36.8M to £34.0M (consolidated) — modest deleveraging - Cash improved from £0.79M to £1.98M — liquidity strengthening - Long-term debt reduced from £14.1M to £13.1M - Deferred tax provision decreased, reducing future obligations - The company has been active for 37 years — demonstrated longevity - Accounts are filed on time with no overdue status

Overall Condition

The group operates a property investment portfolio valued at £73.3M, funded substantially by related-party loans. The business is financially viable but structurally fragile. It is not in acute distress — there are no signs of insolvency, administration, or creditor pressure — but it is in a state of chronic financial underperformance. The going concern is explicitly dependent on parent/group support, which represents a contingent vulnerability.

4. Recommendations

Immediate Actions (0-3 months)

1. Stress-test going concern assumptions: Obtain written commitments or formalised loan agreements from the ultimate controlling party and related companies to replace the current non-binding statement of support. This converts a verbal assurance into a contractual safety net.

2. Cash buffer restoration: Target a minimum cash reserve of £3-5M (consistent with 2021-2023 levels) to provide adequate liquidity headroom. The current £1.98M, while improved, remains thin relative to the scale of operations.

3. Intercompany debtor review: The £51.9M company-level debtor balance should be assessed for recoverability, aging, and credit risk. Given this represents the majority of the company's current assets, any impairment would be material.

Medium-Term Actions (3-12 months)

4. Property portfolio strategic review: The £8.3M revaluation loss warrants a thorough review of the investment property portfolio. Identify underperforming assets, assess whether disposals could release capital and reduce leverage, and consider whether the portfolio mix is optimally configured.

5. Working capital restructuring: Explore opportunities to restructure short-term group loans into longer-term arrangements. Converting even £10-15M of current liabilities to long-term would materially improve the working capital position and reduce apparent liquidity stress.

6. Profitability restoration: The swing from £130k profit to £93k loss, while small in absolute terms, is directionally concerning. Conduct a detailed revenue and cost analysis to identify the drivers and implement corrective measures.

Long-Term Actions (12+ months)

7. Deleveraging strategy: Continue the modest debt reduction trend observed in 2025. A structured programme to reduce total liabilities over 3-5 years would strengthen the balance sheet and reduce dependency on related-party funding.

8. Diversification of funding sources: Consider whether the group could access independent third-party financing (bank facilities, bond issuance, or equity participation) to reduce concentration risk from related-party loans.

9. Governance strengthening: The recent director resignations (October 2026) and the presence of a corporate director (Xxxxxxxname shown to subscribers) suggest governance changes. Ensure the board has appropriate independent oversight and financial expertise to navigate the group's structural challenges.

Prognosis

Short-term (12 months): Stable but guarded. The company is likely to continue operating with the support of the group structure. The improved cash position and modest deleveraging in 2025 provide some reassurance. However, any disruption to related-party funding or further property devaluation could quickly create acute stress.

Medium-term (1-3 years): Cautiously watchful. The trajectory of net asset erosion and property valuation risk creates uncertainty. If the property market stabilises and the group continues deleveraging, the patient could stabilise. If property values continue to decline or the controlling party's support wavers, the prognosis deteriorates significantly.

Key risk factors to monitor: (1) Investment property valuation movements, (2) related-party loan terms and renewals, (3) intercompany debtor recoverability, (4) cash position trends, and (5) any changes in the ultimate controlling party's commitment to the group.

Names of the people mentioned are shown to subscribers. See subscription